Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | GLA | P06280 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | PKM | P14618 | 2/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.53 |
| ▸ | MAOB | P27338 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30590298 | 1.00 | MEN1 (0.59) | MEN1KMT2AKDM4EALDH1A1GLA | |
| SCHEMBL31139739 | 0.76 | RAD51 (0.62) | MEN1KMT2A | |
| SCHEMBL26064259 | 0.76 | RAD51 (0.62) | MEN1KMT2A | |
| SCHEMBL31139754 | 0.76 | RAD51 (0.62) | MEN1KMT2A | |
| SCHEMBL25371445 | 0.76 | RAD51 (0.62) | MEN1KMT2A | |
| SCHEMBL25433017 | 0.76 | RAD51 (0.62) | MEN1KMT2A | |
| SCHEMBL30590340 | 0.76 | RAD51 (0.62) | MEN1KMT2A | |
| SCHEMBL30590293 | 0.74 | MEN1 (0.52) | MEN1KMT2AKDM4EALDH1A1GLA | |
| SCHEMBL25432833 | 0.74 | MEN1 (0.52) | MEN1KMT2AKDM4EALDH1A1GLA | |
| SCHEMBL31139854 | 0.73 | ALDH1A1 (0.55) | MEN1KMT2AKDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4482831-A1 | NOVEL BICYCLIC COMPOUNDS AS RAD51 INHIBITORS | Satya Therapeutics, Inc. (US) | 2025-01-01 | — | — | EP | claimed |
| WO-2023161782-A1 | NOVEL BICYCLIC COMPOUNDS AS RAD51 INHIBITORS | SATYARX PHARMA INNOVATIONS PVT LTD (IN) | 2023-08-31 | — | — | WO | claimed |